Back to search

Article

ACAA2 was a predictor for the prognosis and immunotherapy response of hepatocellular carcinoma

2022-06-10

Abstract excerpt

<h4>Background: </h4> Immunotherapy is the first-line treatment for advanced hepatocellular carcinoma (HCC). However, immunotherapy benefits are limited in certain patients. Therefore, identifying effective biomarkers is important for the efficient use of immunotherapy. In the present study, acetyl-CoA acyltransferase 2 (ACAA2), which was decreased during HCC initiation, was identified as a gene of interest. Metho...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d423e48d-988a-52a9-880a-9782825f9c63
DOI
10.21203/rs.3.rs-1726448/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
ACAA2 was a predictor for the prognosis and immunotherapy response of hepatocellular carcinomaDOI 10.21203/rs.3.rs-1726448/v1
Select a neighboring publication to make it the new centre.